Literature DB >> 16533692

Acute traumatic aortic tear: open versus stent-graft repair.

Hardy Schumacher1, Dittmar Böckler, Hendrik von Tengg-Kobligk, Jens-R Allenberg.   

Abstract

Acute traumatic aortic tear (ATAT) is the second most common cause of deaths in trauma patients (about 8,000 deaths/year in the USA). Due to circumferential aortic disruption, up to 90% die at the scene. Responsible trauma mechanisms are: penetrating (gunshot/stab wounds), iatrogenic (interventional catheterization) and, most frequently, blunt chest trauma (high-speed motor vehicles, falls from heights, crushes, explosions) resulting in injury at the aortic isthmus region (loco typico, about 90%). Severe multiple system injuries (polytrauma), especially to intracranial and intraabdominal organs, are characteristic and prognostically predicitive. Immediate transthoracic open repair of ATAT has a mortality risk of 8% to 33% and paraplegia risk of 2% to 26%. Contrast enhanced CT scan has replaced the classical angiography as the diagnostic tool of choice. Patients with life-threatening multisystem injuries are scheduled for delayed repair after initial stabilization. Currently, the use of endovascular stent-grafts (EVAR) is being investigated. Our personal series confirms that EVAR for ATAT is a viable alternative to open repair while minimizing the morbidity and mortality of the open procedure and having a limited impact on trauma destabilization. The assessment of long-term durability of EVAR is one of the key issues to consider EVAR as the first choice of treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16533692     DOI: 10.1053/j.semvascsurg.2005.11.008

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  9 in total

1.  Electromagnetic navigation for thoracic aortic stent-graft deployment: a pilot study in swine.

Authors:  Nadine Abi-Jaoudeh; Neil Glossop; Michael Dake; William F Pritchard; Alberto Chiesa; Matthew R Dreher; Thomas Tang; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2010-04-09       Impact factor: 3.464

2.  Effects of longitudinal pre-stretch on the mechanics of human aorta before and after thoracic endovascular aortic repair (TEVAR) in trauma patients.

Authors:  Anastasia Desyatova; Jason MacTaggart; Alexey Kamenskiy
Journal:  Biomech Model Mechanobiol       Date:  2019-09-05

3.  Delayed aortic rupture following perforating trauma.

Authors:  Xuefei Yang; Ligang Xia; Kai Pan
Journal:  Ann Transl Med       Date:  2014-10

4.  Endovascular repair of thoracic aortic injury: current thoughts and technical considerations.

Authors:  W Darrin Clouse
Journal:  Semin Intervent Radiol       Date:  2010-03       Impact factor: 1.513

Review 5.  [Clinical requirements of aortic imaging].

Authors:  D Böckler; A Hylik-Dürr; H von Tengg-Kobligk; R Lopez-Benitez; H-U Kauczor; K Klemm
Journal:  Radiologe       Date:  2007-11       Impact factor: 0.635

6.  Injury to the Thoracic Aorta Following Fatal Blunt Trauma: An Autopsy Study.

Authors:  Osvaldo Chiara; Stefania Cimbanassi; Riccardo Zoia
Journal:  Eur J Trauma Emerg Surg       Date:  2008-12-19       Impact factor: 3.693

7.  Open versus endovascular repair of acute aortic transections--a non-randomized single-center analysis.

Authors:  Philipp Geisbüsch; Marcin Leszczynsky; Drosos Kotelis; Alexander Hyhlik-Dürr; Tim F Weber; Dittmar Böckler
Journal:  Langenbecks Arch Surg       Date:  2009-03-03       Impact factor: 3.445

8.  Endovascular and open repair for blunt aortic injury, treated in one clinical institution in Brazil: a case series.

Authors:  Igor Rafael Sincos; Ricardo Aun; Sergio Quilici Belczak; Luciano Dias Nascimento; Boulanger Mioto Netto; Ivan Casella; Erasmo Simao da Silva; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  [Diagnostics and treatment of traumatic aortic injuries].

Authors:  R M Benz; V Makaloski; M Brönnimann; N Mertineit; H von Tengg-Kobligk
Journal:  Unfallchirurg       Date:  2021-07-12       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.